Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion type Assertion NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_head.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_provenance.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion evidence source_evidence_literature NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_provenance.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion SIO_000772 23585456 NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_provenance.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion wasDerivedFrom befree-20150227 NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_provenance.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion wasGeneratedBy ECO_0000203 NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_provenance.